‘Especially concerning’ AMR data for Africa – WHO
Over 70 per cent of bloodstream infections in Africa with two common bacteria are now resistant to mainstay antibiotics, according to the latest WHO report….
Over 70 per cent of bloodstream infections in Africa with two common bacteria are now resistant to mainstay antibiotics, according to the latest WHO report….
Vaccines are being designed with the help of AI to be able to tackle multiple forms of the bird flu virus, in the hope they…
The long-acting HIV prevention jab cabotegravir has a higher acceptability rating among patients than lenacapavir, according to a study. ViiV Healthcare, a global specialist HIV…
Two private equity firms bidding for Bavarian Nordic have increased their offer for the Danish maker of vaccines for mpox, cholera and chikungunya, after shareholders…
US drugmaker Lilly has refused to disclose the amount it is giving as part of a dementia deal with the WHO Foundation. The company announced…
The European Commission has approved a private equity takeover bid for Bavarian Nordic, the Danish maker of vaccines for mpox, cholera and chikungunya, leaving disgruntled…
Vaccine specialist Valneva has refinanced its debt and cut its revenue forecast for this year after the US FDA suspended the licence for its chikungunya…
Helen Clark, the former prime minister of New Zealand, has been appointed as chair of Gavi, the Vaccine Alliance, as the global vaccine group refocuses…
A new model which uses machine learning to forecast the spread of chikungunya has predicted that the mosquito-borne virus will spread much further than expected,…
GlaxoSmithKline has announced that its current chief operating officer Luke Miels would take over as chief executive. The company, one of the world’s biggest drugmakers,…